Zhejiang Jolly Pharmaceutical Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2020
October 29, 2020 at 06:13 am EDT
Share
Zhejiang Jolly Pharmaceutical Co.,LTD announced earnings results for the nine months ended September 30, 2020. For the nine months, the company announced sales was CNY 769.550 million compared to CNY 656.808 million a year ago. Operating income was CNY 73.501 million compared to CNY 39.961 million a year ago. Net income was CNY 62.369 million compared to CNY 38.697 million a year ago. Basic earnings per share from continuing operations was CNY 0.1025 compared to CNY 0.0636 a year ago.
Zhejiang Jolly Pharmaceutical Co., Ltd. is a China-based company principally engaged in research, development, manufacture and sales of medicinal fungi series products. The Companyâs main business is mainly involved in pharmaceutical manufacturing, among which the activities are involved in manufacture and sale of active pharmaceutical ingredients, tablets, capsules, granules, Lyophilized powders and other products. The main products include Wuling series, bailing tablets series and Chinese medicine drinking tablets series, among others. Through its subsidiaries, the Company is also engaged in pharmaceutical circulation.
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD 
